Takeda Pharmaceutical Co. and Daiichi Sankyo Co. are each considering producing vaccines for new and seasonal influenza, a move that would likely sharply increase supplies of domestically produced vaccines, sources said. The companies are considering commencing production as demand for influenza vaccines is expected to grow amid the spread of new influenza in addition to seasonal flu. The government is also beefing up support for vaccine production due to a lack of domestically produced flu vaccines.
Read more:
[JapanTimes] Takeda, Daiichi Sankyo eyeing flu vaccines
Topics: amid-the-spread, daiichi, daiichi-sankyo, domestically-produced, new-influenza, pharmaceutical, produced-flu, spread, the-spread